Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Fresenius Medical Care Corp (FMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,219,182
  • Shares Outstanding, K 612,900
  • Annual Sales, $ 17,911 M
  • Annual Income, $ 1,243 M
  • 36-Month Beta 0.52
  • Price/Sales 1.71
  • Price/Cash Flow 16.50
  • Price/Book 2.66

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.73 +7.65%
on 02/09/18
57.94 -5.75%
on 01/31/18
+0.14 (+0.26%)
since 01/16/18
3-Month
48.54 +12.51%
on 11/20/17
57.94 -5.75%
on 01/31/18
+5.46 (+11.11%)
since 11/16/17
52-Week
40.21 +35.81%
on 02/17/17
57.94 -5.75%
on 01/31/18
+13.59 (+33.13%)
since 02/16/17

Most Recent Stories

More News
Here's Why You Should Sweep Up Quest Diagnostics Right Now

Quest Diagnostics' (DGX) latest acquisitions boost investors' confidence.

DGX : 104.53 (+1.40%)
BIO : 249.04 (+0.90%)
FMS : 54.61 (+0.76%)
PKI : 76.39 (-0.05%)
Becton, Dickinson Gains on Strong Q1 Results & Acquisitions

Acquisition of C.R.Bard and a solid FY18 guidance are key catalysts for Becton, Dickinson (BDX).

BDX : 222.87 (+0.16%)
BIO : 249.04 (+0.90%)
FMS : 54.61 (+0.76%)
PKI : 76.39 (-0.05%)
Quest Diagnostics Buys Fresenius Medical's Shiel Laboratory

Quest Diagnostics (DGX) focuses on driving growth and operational efficiency through acquisitions.

DGX : 104.53 (+1.40%)
MYGN : 32.81 (-1.71%)
FMS : 54.61 (+0.76%)
WMT : 104.78 (+1.50%)
Becton, Dickinson Focuses on Medication Management, Stock Up

Management at Becton, Dickinson and Company (BDX) has been focusing on strengthening its portfolio for long.

CERN : 64.22 (-0.28%)
MCK : 150.50 (+1.21%)
BDX : 222.87 (+0.16%)
FMS : 54.61 (+0.76%)
Fresenius Medical Care North America Sets Record in Surpassing its Kidney Walk Fundraising Goal

Fresenius Medical Care North America (FMCNA) employees put on their walking shoes and raised nearly $300,000, the most amount ever raised by a National Team participating in Kidney...

FMS : 54.61 (+0.76%)
Here's Why You Should Offload Fresenius Medical Stock Now

Fresenius (FMS) grapples with multiple issues. An unfavorable estimate revision trend adds to the woes.

PETS : 44.17 (-1.58%)
NXTM : 24.62 (+4.90%)
FMS : 54.61 (+0.76%)
DVA : 73.65 (-0.26%)
Capital Square 1031 Completes Two DST Offerings of Medical Office Buildings in North Carolina

Capital Square 1031 announced today that its Delaware statutory trust offerings, CS1031 Morganton MOB, DST and CS1031 Louisburg MOB, DST, each comprised of a medical office building occupied by affiliates...

FMS : 54.61 (+0.76%)
Foreign Stock Roundup: Toyota, Gol Linhas Beat, AstraZeneca, Fresenius Miss

Earnings numbers continued to guide Europe's markets last week.

PBR : 12.75 (-0.55%)
ADDYY : 112.0600 (+0.67%)
GOL : 10.44 (+0.38%)
AZN : 33.93 (-0.26%)
TM : 136.20 (+0.68%)
ITUB : 15.64 (-3.87%)
VALE : 14.12 (-0.07%)
FMS : 54.61 (+0.76%)
Fresenius Medical (FMS) Q3 Earnings Miss, FY17 View Intact

Strong growth in Health Care Products and Health Care Services segments drove Fresenius's (FMS) third-quarter revenues. Lackluster performance by the renal pharmaceutical segment is a concern.

PETS : 44.17 (-1.58%)
DGX : 104.53 (+1.40%)
NXTM : 24.62 (+4.90%)
FMS : 54.61 (+0.76%)
Fresenius Medical Care Renal Therapies Group Announces Four Abstracts on Velphoro(R) Accepted for Presentation at the American Society of Nephrology Kidney Week

Fresenius Medical Care Renal Therapies Group announced today that four abstracts on Velphoro(R) (sucroferric oxyhydroxide) have been accepted for presentation at the American Society of Nephrology...

FMS : 54.61 (+0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Fresenius Medical Care provides a range of products for both treatment modalities, hemmodialysis and peritoneal dialysis, and is a full service provider of dialysis care. They provide dialysis treatment and related laboratory and diagnostic services at more than 1,000 dialysis clinics. They manufacture...

See More

Key Turning Points

2nd Resistance Point 55.29
1st Resistance Point 54.95
Last Price 54.61
1st Support Level 54.32
2nd Support Level 54.03

See More

52-Week High 57.94
Last Price 54.61
Fibonacci 61.8% 51.17
Fibonacci 50% 49.07
Fibonacci 38.2% 46.98
52-Week Low 40.21

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.